Aurinia Pharmaceuticals (AUPH) Cash from Operations (2016 - 2026)
Aurinia Pharmaceuticals filings provide 6 years of Cash from Operations readings, the most recent being 45668000.0 for Q4 2025.
- On a quarterly basis, Cash from Operations rose 51.65% to 45668000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 135658000.0, a 205.62% increase, with the full-year FY2025 number at 135658000.0, up 205.62% from a year prior.
- Cash from Operations hit 45668000.0 in Q4 2025 for Aurinia Pharmaceuticals, up from 44449000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 45668000.0 in Q4 2025 to a low of 53541000.0 in Q1 2021.
- Median Cash from Operations over the past 5 years was 8051500.0 (2023), compared with a mean of 4531800.0.
- Biggest five-year swings in Cash from Operations: increased 12.69% in 2022 and later soared 660.62% in 2024.
- Aurinia Pharmaceuticals' Cash from Operations stood at 25922000.0 in 2021, then skyrocketed by 140.31% to 10450000.0 in 2022, then surged by 36.96% to 14312000.0 in 2023, then skyrocketed by 110.41% to 30114000.0 in 2024, then soared by 51.65% to 45668000.0 in 2025.
- The last three reported values for Cash from Operations were 45668000.0 (Q4 2025), 44449000.0 (Q3 2025), and 44241000.0 (Q2 2025) per Business Quant data.